ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,148Medicare Part D Prescriptions Filled, Including Refills

Rank: 472 out of 3593

$443K Total Retail Price of All Prescriptions

Rank: 792 out of 3593

709 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
18% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 709 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

2% of this provider’s 709 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 10,310 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 731 682 1 1
LEVOTHYROXINE SODIUM 564 540 2 4
OMEPRAZOLE 489 437 3 5
LISINOPRIL 447 406 4 2
HYDROCHLOROTHIAZIDE 363 346 5 10
ATENOLOL 345 338 6 11
FUROSEMIDE 337 327 7 9
METFORMIN HCL 330 292 8 6
AMLODIPINE BESYLATE 311 305 9 3
LOVASTATIN 263 251 10 20
PRAVASTATIN SODIUM 251 236 11 13
ALENDRONATE SODIUM 223 222 12 22
POTASSIUM CHLORIDE 205 198 13 24
FOLIC ACID 204 194 14 117
METOPROLOL TARTRATE 203 202 15 8
ENALAPRIL MALEATE 185 166 16 38
WARFARIN SODIUM 181 152 17 18
ALLOPURINOL 139 125 18 35
ATORVASTATIN CALCIUM 130 113 19 15
LOSARTAN POTASSIUM 128 122 20 14
SPIRONOLACTONE 120 117 21 86
GEMFIBROZIL 107 98 22 88
ALPRAZOLAM 99 91 23 37
GLIPIZIDE 95 85 24 40
METOPROLOL SUCCINATE 87 76 25 19
ADVAIR DISKUS 87 81 25 47
CARVEDILOL 84 84 27 23
SERTRALINE HCL 81 80 28 28
ZOLPIDEM TARTRATE 78 77 29 12
VITAMIN D2 77 70 30 124
DIOVAN 75 62 31 46
RANITIDINE HCL 75 47 31 27
PAROXETINE HCL 74 62 33 62
FINASTERIDE 73 73 34 79
LISINOPRIL-HYDROCHLOROTHIAZIDE 71 65 35 26
TERAZOSIN HCL 71 62 35 115
KLOR-CON 10 71 61 35 114
CITALOPRAM HBR 68 68 38 25
DIGOXIN 67 67 39 58
FLUTICASONE PROPIONATE 66 47 40 32
CLOPIDOGREL 66 66 40 30
TAMSULOSIN HCL 63 63 42 33
TRAZODONE HCL 63 61 42 53
GABAPENTIN 63 59 42 16
AMITRIPTYLINE HCL 61 49 R 45 90
CLONIDINE HCL 59 57 46 41
GLYBURIDE 58 57 R 47 55
GLIMEPIRIDE 56 48 48 44
FENOFIBRATE 55 54 49 39
DOXAZOSIN MESYLATE 55 55 49 63
BENAZEPRIL HCL 55 55 49 69
SYNTHROID 52 49 52 51
VERAPAMIL ER 52 49 52 99
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 6, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.